130 related articles for article (PubMed ID: 25572982)
1. Rerouting the metabolic pathway of (18)F-labeled peptides: the influence of prosthetic groups.
Richter S; Wuest M; Bergman CN; Way JD; Krieger S; Rogers BE; Wuest F
Bioconjug Chem; 2015 Feb; 26(2):201-12. PubMed ID: 25572982
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer.
Richter S; Wuest M; Krieger SS; Rogers BE; Friebe M; Bergmann R; Wuest F
Nucl Med Biol; 2013 Nov; 40(8):1025-34. PubMed ID: 23969085
[TBL] [Abstract][Full Text] [Related]
3. Metabolically Stabilized (68)Ga-NOTA-Bombesin for PET Imaging of Prostate Cancer and Influence of Protease Inhibitor Phosphoramidon.
Richter S; Wuest M; Bergman CN; Krieger S; Rogers BE; Wuest F
Mol Pharm; 2016 Apr; 13(4):1347-57. PubMed ID: 26973098
[TBL] [Abstract][Full Text] [Related]
4. A comparative PET imaging study of
Ferguson S; Wuest M; Richter S; Bergman C; Dufour J; Krys D; Simone J; Jans HS; Riauka T; Wuest F
Nucl Med Biol; 2020; 90-91():74-83. PubMed ID: 33189947
[TBL] [Abstract][Full Text] [Related]
5. A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging.
Pan D; Xu YP; Yang RH; Wang L; Chen F; Luo S; Yang M; Yan Y
Amino Acids; 2014 Jun; 46(6):1481-9. PubMed ID: 24633452
[TBL] [Abstract][Full Text] [Related]
6. PET of tumors expressing gastrin-releasing peptide receptor with an 18F-labeled bombesin analog.
Dijkgraaf I; Franssen GM; McBride WJ; D'Souza CA; Laverman P; Smith CJ; Goldenberg DM; Oyen WJ; Boerman OC
J Nucl Med; 2012 Jun; 53(6):947-52. PubMed ID: 22570329
[TBL] [Abstract][Full Text] [Related]
7. PEGylation of (99m)Tc-labeled bombesin analogues improves their pharmacokinetic properties.
Däpp S; García Garayoa E; Maes V; Brans L; Tourwé DA; Müller C; Schibli R
Nucl Med Biol; 2011 Oct; 38(7):997-1009. PubMed ID: 21982571
[TBL] [Abstract][Full Text] [Related]
8. Targeting Prostate-Specific Membrane Antigen (PSMA) with F-18-Labeled Compounds: the Influence of Prosthetic Groups on Tumor Uptake and Clearance Profile.
Bouvet V; Wuest M; Bailey JJ; Bergman C; Janzen N; Valliant JF; Wuest F
Mol Imaging Biol; 2017 Dec; 19(6):923-932. PubMed ID: 28639122
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro and in vivo evaluation of SiFA-tagged bombesin and RGD peptides as tumor imaging probes for positron emission tomography.
Lindner S; Michler C; Leidner S; Rensch C; Wängler C; Schirrmacher R; Bartenstein P; Wängler B
Bioconjug Chem; 2014 Apr; 25(4):738-49. PubMed ID: 24666287
[TBL] [Abstract][Full Text] [Related]
10. 18F-labeled bombesin analog for specific and effective targeting of prostate tumors expressing gastrin-releasing peptide receptors.
Honer M; Mu L; Stellfeld T; Graham K; Martic M; Fischer CR; Lehmann L; Schubiger PA; Ametamey SM; Dinkelborg L; Srinivasan A; Borkowski S
J Nucl Med; 2011 Feb; 52(2):270-8. PubMed ID: 21233180
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, 18F-labeling, and in vitro and in vivo studies of bombesin peptides modified with silicon-based building blocks.
Höhne A; Mu L; Honer M; Schubiger PA; Ametamey SM; Graham K; Stellfeld T; Borkowski S; Berndorff D; Klar U; Voigtmann U; Cyr JE; Friebe M; Dinkelborg L; Srinivasan A
Bioconjug Chem; 2008 Sep; 19(9):1871-9. PubMed ID: 18754574
[TBL] [Abstract][Full Text] [Related]
12. Preparation and evaluation of bombesin peptide derivatives as potential tumor imaging agents: effects of structure and composition of amino acid sequence on in vitro and in vivo characteristics.
Okarvi SM; Jammaz IA
Nucl Med Biol; 2012 Aug; 39(6):795-804. PubMed ID: 22381782
[TBL] [Abstract][Full Text] [Related]
13. Novel glycated [99mTc(CO)3]-labeled bombesin analogues for improved targeting of gastrin-releasing peptide receptor-positive tumors.
Schweinsberg C; Maes V; Brans L; Bläuenstein P; Tourwé DA; Schubiger PA; Schibli R; García Garayoa E
Bioconjug Chem; 2008 Dec; 19(12):2432-9. PubMed ID: 19053304
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo characterization of novel 18F-labeled bombesin analogues for targeting GRPR-positive tumors.
Mu L; Honer M; Becaud J; Martic M; Schubiger PA; Ametamey SM; Stellfeld T; Graham K; Borkowski S; Lehmann L; Dinkelborg L; Srinivasan A
Bioconjug Chem; 2010 Oct; 21(10):1864-71. PubMed ID: 20857927
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and radiopharmacological evaluation of ⁶⁴Cu-labeled bombesin analogs featuring a bis(2-pyridylmethyl)-1,4,7-triazacyclononane chelator.
Bergmann R; Ruffani A; Graham B; Spiccia L; Steinbach J; Pietzsch J; Stephan H
Eur J Med Chem; 2013; 70():434-46. PubMed ID: 24184988
[TBL] [Abstract][Full Text] [Related]
16. 18F-labeled BBN-RGD heterodimer for prostate cancer imaging.
Li ZB; Wu Z; Chen K; Ryu EK; Chen X
J Nucl Med; 2008 Mar; 49(3):453-61. PubMed ID: 18287274
[TBL] [Abstract][Full Text] [Related]
17. Radiochemical investigations of [188Re(H2O)(CO)3-diaminopropionic acid-SSS-bombesin(7-14)NH2]: syntheses, radiolabeling and in vitro/in vivo GRP receptor targeting studies.
Smith CJ; Sieckman GL; Owen NK; Hayes DL; Mazuru DG; Volkert WA; Hoffman TJ
Anticancer Res; 2003; 23(1A):63-70. PubMed ID: 12680195
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a novel GRPR antagonist for prostate cancer PET imaging: [
Mansour N; Paquette M; Ait-Mohand S; Dumulon-Perreault V; Guérin B
Nucl Med Biol; 2018 Jan; 56():31-38. PubMed ID: 29154145
[TBL] [Abstract][Full Text] [Related]
19. Comparison of [(11)C]Choline ([(11)C]CHO) and [(18)F]Bombesin (BAY 86-4367) as Imaging Probes for Prostate Cancer in a PC-3 Prostate Cancer Xenograft Model.
Schwarzenböck SM; Schmeja P; Kurth J; Souvatzoglou M; Nawroth R; Treiber U; Kundt G; Berndt S; Graham K; Senekowitsch-Schmidtke R; Schwaiger M; Ziegler SI; Dinkelborg L; Wester HJ; Krause BJ
Mol Imaging Biol; 2016 Jun; 18(3):393-401. PubMed ID: 26483088
[TBL] [Abstract][Full Text] [Related]
20. Novel series of (177)Lu-labeled bombesin derivatives with amino acidic spacers for selective targeting of human PC-3 prostate tumor cells.
Pujatti PB; Santos JS; Couto RM; Melero LT; Suzuki MF; Soares CR; Grallert SR; Mengatti J; De Araújo EB
Q J Nucl Med Mol Imaging; 2011 Jun; 55(3):310-23. PubMed ID: 21532543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
